Company Aarti Pharmalabs Limited

AARTIPHARM

INE0LRU01027

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 09:19:27 11/06/26 pm AEST			5-day change	1st Jan Change
622.35 ^INR	+0.02%		+0.08%	-17.28%

26/05	Aarti Pharmalabs Limited, Q4 2026 Earnings Call, May 26, 2026
26/05	Aarti Pharmalabs' Fiscal Q4 Consolidated Profit Slumps	MT

Business description: Aarti Pharmalabs Limited

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan.

Number of employees: 2,162

Sales by Activity: Aarti Pharmalabs Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Pharmeceuticals	-	12B	19.45B	18.53B	21.15B

See all business segments

Geographical breakdown of sales: Aarti Pharmalabs Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Outside India	-	-	-	8.44B	12.19B
India	-	-	-	9.74B	8.69B
Unallocated	-	-	-	345M	274M

See all geographic segments

Executive Committee: Aarti Pharmalabs Limited

Manager	Title	Age	Since
Narendra Jagannath Salvi CEO	Chief Executive Officer	61	17/10/2022
Hetal Gogri Gala CEO	Chief Executive Officer	50	17/10/2022
Piyush Lakhani DFI	Director of Finance/CFO	-	17/10/2022
Bharat S. Patravale CTO	Chief Tech/Sci/R&D Officer	-	01/10/2022
Sudhakar Shetty ADM	Chief Administrative Officer	-	-

See AARTI PHARMALABS LIMITED governance

Composition of the Board of Directors: Aarti Pharmalabs Limited

Director	Title	Age	Since
Hetal Gogri Gala BRD	Director/Board Member	50	17/10/2022
Rajendra Vallabhaji Gogri BRD	Director/Board Member	66	07/08/2021
Rashesh Chandrakant Gogri CHM	Chairman	52	01/01/2022
Narendra Jagannath Salvi BRD	Director/Board Member	61	17/10/2022
Jeenal Kenil Savla BRD	Director/Board Member	-	-
Chandrakant V. Gogri BRD	Director/Board Member	79	-
Parimal Hasmukhlal Desai BRD	Director/Board Member	76	-
Vinay Gopal Nayak BRD	Director/Board Member	69	17/10/2022
Rupal Anand Vora BRD	Director/Board Member	63	-
Vilas Gajanan Gaikar BRD	Director/Board Member	65	-

Composition of the Board of Directors

Shareholders: Aarti Pharmalabs Limited

Name	Stocks	%	Valuation
Life Insurance Corporation of India (Investment Portfolio) 5.275 %	4,782,452	5.275 %	32 M ₹
Rashesh Chandrakant Gogri 4.23 %	3,834,404	4.23 %	26 M ₹
Jaya Chandrakant Gogri 3.535 %	3,204,310	3.535 %	21 M ₹
Anushakti Enterprise Private Ltd. 3.301 %	2,992,950	3.301 %	20 M ₹
Labdhi Business Trust 3.134 %	2,841,504	3.134 %	19 M ₹

List of AARTI PHARMALABS LIMITED shareholders

Company details: Aarti Pharmalabs Limited

Aarti Pharmalabs Ltd.

Embassy Park 247

400083, Mumbai

+91 22 6943 6100

http://www.aartipharmalabs.com

address Aarti Pharmalabs Limited(AARTIPHARM)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AARTI PHARMALABS LIMITED	+0.02%	+0.08%	-32.61%	+57.72%	592M
ELI LILLY AND COMPANY	+1.75%	+3.02%	+43.36%	+160.32%	1,013B
JOHNSON & JOHNSON	+0.56%	+5.06%	+54.40%	+49.92%	574B
ABBVIE INC.	+0.30%	+0.27%	+17.78%	+63.76%	397B
ROCHE HOLDING AG	-0.37%	+4.97%	+21.24%	+15.95%	324B
ASTRAZENECA PLC	+0.85%	+0.18%	+24.50%	+14.78%	280B
NOVARTIS AG	+2.10%	+4.92%	+25.30%	+33.80%	273B
AMGEN INC.	+3.91%	+1.32%	+20.00%	+61.10%	182B
NOVO NORDISK A/S	-0.19%	-0.46%	-45.32%	-48.35%	194B
GILEAD SCIENCES, INC.	+3.48%	-2.54%	+15.18%	+61.69%	151B
Average	+1.22%	+2.39%	+14.38%	+47.07%	338.92B
Weighted average by Cap.	+1.20%	+3.99%	+29.51%	+72.61%